CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia

Abstract Background Acquired aplastic anemia (AA) is characterized by deficiency or dysfunction of the bone marrow (BM) microenvironment. However, little is known about the impairment of BM-derived mesenchymal stem cells (MSCs) in AA patients. Methods We used Illumina HiSeqTM 2000 sequencing, quanti...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Shihong Lu, Meili Ge, Yizhou Zheng, Jianping Li, Xiaoming Feng, Sizhou Feng, Jinbo Huang, Ying Feng, Donglin Yang, Jun Shi, Fang Chen, Zhongchao Han
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2017-08-01
Serie:	Stem Cell Research & Therapy
Soggetti:	Aplastic anemia Mesenchymal stem cells CD106 hematopoiesis
Accesso online:	http://link.springer.com/article/10.1186/s13287-017-0620-4
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!